A 39-year-old man with primary synovial sarcoma of the lung remained disease-free for 2 years following gross surgical excision without adjuvant treatment.
Case Report (n=1)
No
Primary synovial sarcoma of the lung is a rare tumor requiring histopathological evaluation and exclusion of other primary sites for accurate diagnosis.
Primary synovial sarcoma of the lung (PSSL) is a rare tumour with only 0.5% incidence among other primary malignant lung tumours. Published medical literature regarding the natural history treatment protocol and clinical outcomes of PSSL remains limited. Here, we present a case of a 39-year-old man with primary synovial sarcoma with long-term follow-up, which was initially viewed as a metastasis from another unknown site. After evaluating histopathologically from the specimen post left lung metastasectomy and ruling out any other site for neoplastic changes, the diagnosis of PSSL was confirmed. Furthermore, this article reviews the literature and discusses various aspects of PSSL, including clinical presentation, radiological imaging and pathological characteristics, diagnostic dilemma, management and prognosis. This paper serves to provide an update and aims to enhance the understanding of PSSL. Timely diagnosis and treatment are imperative to achieve improved outcomes.
Pandey et al. (Sun,) conducted a case report in Primary synovial sarcoma of the lung (n=1). Surgical excision (Left lung metastasectomy) was evaluated on Disease-free survival. A 39-year-old man with primary synovial sarcoma of the lung remained disease-free for 2 years following gross surgical excision without adjuvant treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: